Tumour selective redox activity of economically synthesised Ferromarin in triple-negative breast cancer.
Breast cancer is one of the most prevalent malignancies worldwide, particularly among women, with triple-negative breast cancer (TNBC) representing the most aggressive subtype owing to the lack of targeted therapies and its poor clinical prognosis. Conventional chemotherapeutic agents are often limited by non-selective...